Angiotensin receptor - neprilysin inhibiton (ARNI) – A novel therapeutic concept for management of hypertension and heart failure

Author： Kjeldsen Sverre E.   Hedner Thomas   Narkiewicz Krzysztof   Oparil Suzanne  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.21, Iss.6, 2012-12, pp. : 329-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic Concept

By JOHNSTON COLIN I.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 9-13

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin Receptor Blockers in Chronic Heart Failure: Clinical Implications and Molecular Mechanisms

By  

Current Cardiology Reviews, Vol. 3, Iss. 4, 2007-11 ,pp. : 296-303

Bentham Science Publishers

Access to resources Recommend Favorite

Algorithm for therapeutic management of acute heart failure syndromes

By Chatti Ramzi   Fradj Nabil   Trabelsi Wissem   Kechiche Hakim   Tavares Miguel   Mebazaa Alexandre  

Heart Failure Reviews, Vol. 12, Iss. 2, 2007-06 ,pp. : 113-117

Springer Publishing Company

Access to resources Recommend Favorite

Ryanodine Receptor - A Novel Therapeutic Target in Heart Disease

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite

Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade

By Funder John W  

Future Cardiology, Vol. 2, Iss. 5, 2006-09 ,pp. : 535-541

Future Medicine

Access to resources Recommend Favorite